HighTower Advisors
NVO

HighTower Advisors’s Novo Nordisk NVO Stock Holding History

HighTower Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-100
Closed -$126 – 3988
2024
Q3 		$126 Buy
+100
New +$13.3K ﹤0.01% 3716
2024
Q2 		– Sell
-200
Closed -$3.25K – 3838
2024
Q1 		$3.25K Buy
+200
New +$23.8K ﹤0.01% 3464
2023
Q2 		– Sell
-1,000
Closed -$17.5K – 3607
2023
Q1 		$17.5K Buy
+1,000
New +$70.9K ﹤0.01% 3159

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

HighTower Advisors's NVO Position: Q1 2026 in Review

HighTower Advisors increased its Novo Nordisk (NVO) stake by 28% in Q1 2026, buying an estimated $2.46M and bringing the position to 235,066 shares worth $8.64M. The position accounts for 0.01% of the portfolio, ranked #949.

HighTower Advisors first reported a position in NVO in Q2 2013 and has held it in 52 quarters since. The position peaked at $72.9M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • HighTower Advisors held 235,066 shares of Novo Nordisk worth $8.64M as of Q1 2026.
  • HighTower Advisors bought 51,865 Novo Nordisk shares in Q1 2026, an estimated $2.46M.
  • Novo Nordisk made up 0.01% of HighTower Advisors's portfolio in Q1 2026, its #949 holding.
  • HighTower Advisors first reported a position in Novo Nordisk in Q2 2013 and has held it in 52 quarters since.
  • HighTower Advisors's Novo Nordisk position peaked at $72.9M in Q2 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.